Drug Trial Radar · NCT07668388
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Jun 22, 2026
Primary completion
Oct 4, 2027
Study completion Nov 15, 2027
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Jun 25, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is testing UBT251 in participants with type 2 diabetes. The purpose of this clinical study is to find out if UBT251 is effective and safe for treating participants with type 2 diabetes. Participants will either get UBT251, UBT251 placebo, semaglutide, or semaglutide placebo. Which treatment participants get is decided by chance. UBT251 is the treatment being tested and is not yet available for doctors to prescribe, while semaglutide is a medicine used to treat type 2 diabetes that doctors can already prescribe.
Conditions
- Diabetes Mellitus, Type 2
Interventions
UBT251Drug
UBT251 will be administered subcutaneously once-weekly.
UBT251 PlaceboDrug
UBT251 placebo will be administered subcutaneously once-weekly.
SemaglutideDrug
Semaglutide will be administered subcutaneously once-weekly.
Semaglutide PlaceboDrug
Semaglutide placebo will be administered subcutaneously once-weekly.
Primary outcomes
What the sponsor says the trial is designed to measure.
- UBT251: Change in glycated haemoglobin (HbA1c)Time frame: From baseline (week 0) to 12 weeks on a given maintenance dose (week 16, 28 and 40)
Locations
70 sites in 9 countries. Site status is shown where the registry gives one.
Flourish Research
Birmingham, Alabama · Recruiting
Ark Clinical Research
Fountain Valley, California · Recruiting
Ark Clinical Research
Long Beach, California · Recruiting
Los Angeles Institute for Metabolic Research
Los Angeles, California · Recruiting
Catalina Research Institute, LLC
Montclair, California · Recruiting
Encore Medical Research LLC
Hollywood, Florida · Recruiting
South Broward Research LLC
Miramar, Florida · Recruiting
Encore Medical Research of Weston
Weston, Florida · Recruiting
Midwest Inst For Clin Res
Indianapolis, Indiana · Not yet recruiting
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas · Recruiting
MD Medical Research
Oxon Hill, Maryland · Recruiting
PharmQuest
Greensboro, North Carolina · Not yet recruiting
KDCILM, LLC & Accellacare US, Inc.
Wilmington, North Carolina · Recruiting
Plains Clinical Research Center, LLC_Fargo
Fargo, North Dakota · Not yet recruiting
Preferred Primary Care Physicians, Inc.
Uniontown, Pennsylvania · Recruiting
Monroe Biomedical Research, LLC
North Charleston, South Carolina · Recruiting
LifeDoc Health
Memphis, Tennessee · Recruiting
IMA Clinical Research
Austin, Texas · Recruiting
Private Practice - Dr. Laila A. Hassan
Houston, Texas · Recruiting
Radiance Clinical Research
Lampasas, Texas · Recruiting
Quality Research Inc
San Antonio, Texas · Recruiting
Tekton Research Inc
San Antonio, Texas · Recruiting
Consano Clin Res-Shavano Park
Shavano Park, Texas · Recruiting
Chrysalis Clinical Research
St. George, Utah · Recruiting
The Vancouver Clinic
Vancouver, Washington · Not yet recruiting
Castle Hill Medical Centre
Castle Hill, New South Wales, Australia · Recruiting
Novatrials
Charlestown, New South Wales, Australia · Recruiting
Hunter Medical Research Institute - Endocrinology and Diabetes
New Lambton Heights, New South Wales, Australia · Not yet recruiting
Roger Chih Yu Chen
Sydney, New South Wales, Australia · Recruiting
Royal Adelaide Hospital - Cardiology Department
Adelaide, South Australia, Australia · Recruiting
Baker Heart and Diabetes Institute
Melbourne, Victoria, Australia · Recruiting
Herz- und Diabeteszentrum NRW - Bad Oeynhausen
Bad Oeynhausen, Germany · Recruiting
Medizinisches Versorgungszentrum Am Bahnhof Spandau GbR
Berlin, Germany · Recruiting
DSP Bochum, Diabetes- und Stoffwechselpraxis
Bochum, Germany · Not yet recruiting
Studiengesellschaft Dres. Könemann/Steinmann GbR
Bünde, Germany · Not yet recruiting
InnoDiab Forschung GmbH
Essen, Germany · Recruiting
Mesut Durmaz, Hof
Hof, Germany · Recruiting
CRS Clinical Research Services Mannheim GmbH (hVIVO Mannheim)
Mannheim, Germany · Recruiting
Versdias - Diabetologikum Amberg
Amberg, Bavaria, Germany · Recruiting
Szent Margit Rendelőintézet Nonprofit Kft.
Budapest, Hungary · Recruiting
Showing 40 of 70 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.